Valuation: Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.

Market Cap 1.36TCr 200.28Cr 175.54Cr 162.65Cr 149.71Cr 282.3Cr 19TCr 285.72Cr 1.94TCr 759.65Cr 9.45TCr 751.8Cr 735.62Cr 33TCr P/E 2026 *
103x
P/E 2027 * 96.1x
Enterprise Value 1.36TCr 200.28Cr 175.54Cr 162.65Cr 149.71Cr 282.3Cr 19TCr 285.72Cr 1.94TCr 759.65Cr 9.45TCr 751.8Cr 735.62Cr 33TCr EV / Sales 2026 *
17.8x
EV / Sales 2027 * 13.6x
Free-Float
65.55%
Yield 2026 *
-
Yield 2027 * -
20/05 Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Approves Final Cash Dividend on A Shares for 2025, Payable on 16 July 2026 CI
23/04 Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
22/04 Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
31/03 Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 24, 2025. CI
02/03 Hainan Lingqing Digital Pharmaceutical Technology Co., Ltd. announced that it has received CNY 450 million in funding from Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. CI
01/03 Kemai Biotech Co., Ltd. announced that it has received funding from Jiangsu Hualan New Pharmaceutical Material Co.,Ltd., Wuxi Capital Group Co.,Ltd, XtalPi Holdings Limited CI
21/01 Hainan Lingqing Digital Pharmaceutical Technology Co., Ltd. announced that it expects to receive CNY 450 million in funding from Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. CI
09/01 Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. entered into a Share Transfer Agreement to acquire 35% stake in Ningbo Guangfeng Capsule Co., Ltd. from Ningbo Sprague Biotechnology Co., Ltd. for CNY 8.5 million. CI
05/01 Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 24, 2025. CI
22/25/22 Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
09/25/09 Tranche Update on Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.'s Equity Buyback Plan announced on June 24, 2025. CI
26/25/26 Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
24/25/24 Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. announces an Equity Buyback for CNY 200 million worth of its shares. CI
1 day+6.22%
1 week-17.42%
Current month-39.07%
1 month-36.37%
3 months+2.28%
6 months+12.82%
Current year+61.72%
1 week 50.12
Extreme 50.12
81.49
1 month 50.12
Extreme 50.12
110.32
Current year 36.19
Extreme 36.1923
110.32
1 year 19.62
Extreme 19.6154
110.32
3 years 10.13
Extreme 10.1302
110.32
5 years 10.13
Extreme 10.1302
110.32
10 years 10.13
Extreme 10.1302
110.32
Manager TitleAgeSince
Chief Executive Officer 44 16/10/2009
Director of Finance/CFO 53 16/06/2019
Corporate Officer/Principal 63 16/10/2009
Director TitleAgeSince
Director/Board Member 47 22/03/2022
Director/Board Member 69 16/10/2009
Chairman 44 22/03/2022
Date Insider Type Main position Quantity % Market Cap.
20/04/26 Buy

Chief Executive Officer

100 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+6.22%-17.42%+202.05%+226.25% 200.28Cr
-0.58%+2.12%+24.88%+29.73% 2.9TCr
+0.60%+2.57%+8.24%+23.62% 2.73TCr
-1.25%+0.65%+79.84%+149.19% 758.58Cr
+0.12%+1.90%+5.66% - 624.16Cr
+0.83%+3.63%+0.98%+18.36% 624.5Cr
-1.97%-10.33%-10.62%+24.32% 415.78Cr
-1.96%+1.20%+30.35%+108.84% 389.7Cr
-2.10%-0.11%+31.14%+51.78% 364.66Cr
+6.03%+19.21%+102.59%+86.19% 246.11Cr
Average -0.01%+0.74%+47.51%+79.81% 925.01Cr
Weighted average by Cap. -0.16%+2.17%+26.35%+47.90%

Financials

2026 *2027 *
Net sales 76Cr 11Cr 9.88Cr 9.16Cr 8.43Cr 16Cr 1.09TCr 16Cr 109.29Cr 43Cr 532.16Cr 42Cr 41Cr 1.84TCr 100Cr 15Cr 13Cr 12Cr 11Cr 21Cr 1.42TCr 21Cr 142.47Cr 56Cr 693.73Cr 55Cr 54Cr 2.4TCr
Net income 13Cr 1.94Cr 1.7Cr 1.58Cr 1.45Cr 2.74Cr 186.99Cr 2.77Cr 19Cr 7.36Cr 92Cr 7.29Cr 7.13Cr 316.41Cr 14Cr 2.08Cr 1.82Cr 1.69Cr 1.55Cr 2.93Cr 200.28Cr 2.97Cr 20Cr 7.89Cr 98Cr 7.81Cr 7.64Cr 338.9Cr
Net Debt - -
Logo Jiangsu Hualan New Pharmaceutical Material Co.,Ltd.
Jiangsu Hualan New Pharmaceutical Material Co Ltd is a China-based company primarily engaged in the research, development, production and sales of packaging materials for injectable pharmaceuticals that come into direct contact with the drug. The Company’s main products include various types of coated rubber stoppers and conventional rubber stoppers. The Company also produces rubber components for pen syringes (cassette vials), assemblies for plastic infusion containers, silicone rubber products, medical devices, and accessories. The Company's pharmaceutical rubber stoppers are used to encapsulate various types of injectable drugs, vaccines, biological agents, antibiotics, infusions, blood collection containers, and anti-tumor drugs. The Company distributes its products within the domestic market and to overseas markets.
Employees
945
Date Price Change Volume
21/26/21 CN¥63.57 +6.22% 1,11,46,344
20/26/20 CN¥59.85 -12.15% 88,30,227
17/26/17 CN¥68.13 -7.14% 65,55,202
16/26/16 CN¥73.37 -8.29% 45,91,714
15/26/15 CN¥80.00 +3.93% 60,72,765
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
63.57CNY
Average target price
68.05CNY
Spread / Average Target
+7.05%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 301093 Stock